Cartherics is pleased to announce that Dr Madeline Cao, Research Fellow, will be presenting at Australia Biologics 2023 at Crown Promenade, Melbourne.
The Australia Biologics Festival 2023 is Australia’s premier conference that aims to gather the innovators, pioneers, leaders in the biologics fraternity including biologics, biosimilars, vaccines, cell and gene therapy (CGT) and evolving therapeutics to showcase the latest from ideation to commercialisation phase and beyond.
Madeline’s presentation titled, ‘Off-the-shelf’ cancer cell therapies: manufacturing from research to the clinic, will take place on Wednesday 1st March at 3.45pm AEDT. The presentation will focus on the scale-up process development of CTH-401, Cartherics’ first allogeneic therapy which is a multi-edited natural killer (NK) cell immunotherapy derived from induced pluripotent stem cells.
In conjunction to clinical practice and research experience, Dr Cao has developed a strong expertise in stem cell biology and a passion in utilising stem cells to develop innovative therapeutic strategies to help patients fight cancer.
Highlights of Madeline’s presentation include:
- Introduction to our lead ‘off-the-shelf’ product: CTH-401
- Manufacturing process development from research to clinic
- Challenges for the process development
“The Biologics Festival will provide a great opportunity for Cartherics to leverage partnership opportunities as well as expand innovation and manufacturing opportunities in Australia; I’m also looking forward to meeting and engaging with senior leaders in the industry,” said Dr Cao.